K. Nam

581 citations
9 papers · 377 · 1 hit paper · h-index 4

Impact in

  • Oncology top 10%
    • Cancer Immunotherapy and Biomarkers
    • Colorectal Cancer Treatments and Studies
  • Surgery top 10%
    • Bladder and Urothelial Cancer Treatments
    • Urinary and Genital Oncology Studies
    • Esophageal Cancer Research and Treatment

Papers in

    • Bladder and Urothelial Cancer Treatments 8
    • Urinary and Genital Oncology Studies 2
    • Cancer Immunotherapy and Biomarkers 6
    • Cancer Treatment and Pharmacology 1

K. Nam

8 papers receiving 375 citations

K. Nam's Hit Papers

Randomized phase III KEYNOTE-045 trial of pembrolizumab versus paclitaxel, docetaxel, or vinflunine in recurrent advanced urothelial cancer: results of >2 years of follow-up 2019 · 306 citations
3060+2+4Years since publication100200300

Peers

K. Nam
Comparison fields: 5 of 29
  • Oncology 269
  • Surgery 281
  • Pulmonary and Respiratory Medicine 88
  • Urology 16
  • Cancer Research 22
Replace J L Lee with:
J L Lee South Korea
Radhika Walling United States
Nick van Dijk Netherlands
Yao Yu United States
Akinori Minato Japan
Urbano Anido Herranz Spain
Benjamin Miron United States
Sally Hanna Canada
Zhisong He China
Michele Sisani Italy
K. Nam relative to J L Lee South Korea J L Lee's profile →
Citations per field
00.5×1.5×
J L Lee · 1×
Citations per year

Countries citing papers authored by K. Nam

Since Specialization
Citations

This map shows the geographic impact of K. Nam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Nam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Nam more than expected).

Fields of papers citing papers by K. Nam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Nam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Nam. The network helps show where K. Nam may publish in the future.

Co-authors

The 25 scholars most cited alongside K. Nam, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with K. Nam Line = papers co-authored together K. Nam links everyone, so they are left out of the graph.

All Works

9 of 9 papers shown
#Work
1
Randomized phase III KEYNOTE-045 trial of pembrolizumab versus paclitaxel, docetaxel, or vinflunine in recurrent advanced urothelial cancer: results of >2 years of follow-up
Hit paper breakdown →
2019306
2 202047
3 20189
4 20199
5 20162
6 20202
7 20191
8 20191
9 20230

About K. Nam

K. Nam is a scholar working on Surgery, Oncology, Molecular Biology, Biotechnology and Pulmonary and Respiratory Medicine, having authored 9 papers that have together received 377 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (8 papers), Cancer Immunotherapy and Biomarkers (6 papers), Epigenetics and DNA Methylation (2 papers), Urinary and Genital Oncology Studies (2 papers), Cancer Research and Treatments (2 papers), Cancer Treatment and Pharmacology (1 paper), Advanced Breast Cancer Therapies (1 paper) and Cancer therapeutics and mechanisms (1 paper). The work is most often cited by research in Oncology (269 citations), Surgery (281 citations), Pulmonary and Respiratory Medicine (88 citations), Urology (16 citations) and Cancer Research (22 citations). K. Nam has collaborated with scholars based in United States, Netherlands and Canada. Frequent co-authors include Yves Fradet, Dean F. Bajorin, Tara L. Frenkl, Ronald de Wit, Winald R. Gerritsen, Toni K. Choueiri, Andrea Necchi, Daniel P. Petrylak, Cora N. Sternberg and Howard Gurney. Their work appears in journals such as Annals of Oncology, European Urology Open Science and European Urology Supplements.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact